c.vasquez

TL2 · Basel

Contributes reviews on supplier material. Based in Basel.

Joined 4 May 2025 · last posted 2d

74 posts, newest first. Showing up to 150.

Coming back to: Preparing for an appointment: one page, three questions Replied, post #53 · Clinical › Prescriber conversations · 26 Jul 2026 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Follow-up: How compounding permissions changed when supply normalised Replied, post #69 · Sourcing › Regulatory · 25 Jul 2026 · 13 likes On post #65 — agreed on the reasoning, with one qualification. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the…
Pooling trials with different estimands Replied, post #123 · Evidence › Meta-analyses · 23 Jul 2026 · 11 likes Post #121 and I disagree about the size of the effect, not about the direction. Fixed-effect and random-effects models answer different questions. The first assumes one…
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #23 · Practice › Side effects · 21 Jul 2026 · 2 likes Post #22 and I disagree about the size of the effect, not about the direction. Small methodological point on Taste changes and food aversion: repeating a measurement is…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #45 · Pharmacology › Receptor biology · 15 Jul 2026 · 30 likes That reframing is the whole thing. The facts I already had.
Substitution between formats during a shortage — what changed since Replied, post #8 · Access › Shortages · 11 Jul 2026 · 20 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Revisiting: Protein density versus volume when you cannot eat much Replied, post #48 · Nutrition & Training › Protein & intake · 9 Jul 2026 · 1 like Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #7 · Clinical › Comorbidities · 9 Jul 2026 · 13 likes I disagree with the framing of Osteoarthritis and mechanical versus metabolic above, and I think it is a substantive disagreement rather than a terminological one.…
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #10 · Lounge › Off topic · 20 Jun 2026 · 31 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does. On balance I…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #80 · Sourcing › Vendor reports · 7 Jun 2026 · 2 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. A single observation, in a…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #43 · Wellbeing › Sleep · 25 May 2026 · 8 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
Preservatives: function, testing, and limits — one year on Replied, post #15 · Pharmacology › Formulation chemistry · 8 May 2026 · 0 likes I changed my mind about Preservatives after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary…
What a certificate commits its issuer to — one year on Replied, post #63 · Analytics › COA interpretation · 7 May 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #40 · Practice › Reconstitution · 6 May 2026 · 11 likes A 0.3 mL barrel has more space between graduations than a 1 mL barrel for the same volume, which is the entire practical argument for the smaller syringe. Resolution,…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #104 · Compounds › Tirzepatide · 30 Apr 2026 · 0 likes 2.5 mg starting dose is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
[2026 update] Thyroid function tests during substantial weight change Replied, post #39 · Clinical › Bloodwork · 14 Apr 2026 · 1 like This follows post #36 rather than contradicting it. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If…
[2026 update] What a purity-only report leaves out Replied, post #89 · Sourcing › Independent verification · 13 Apr 2026 · 9 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #51 · Outcomes › Body composition · 1 Apr 2026 · 6 likes Something worth flagging about Lean mass preservation: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and…
Foaming during reconstitution and whether it matters — the long version Replied, post #83 · Practice › Reconstitution · 1 Apr 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #64 · Compounds › Tirzepatide · 31 Mar 2026 · 6 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #11 · Lounge › Introductions · 26 Mar 2026 · 10 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Second pass at: What pooling buys you and what it destroys Replied, post #30 · Evidence › Meta-analyses · 23 Mar 2026 · 7 likes Reframing pooling buys slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #73 · Pharmacology › Pharmacokinetics · 16 Mar 2026 · 0 likes Coming back to post #71, because the follow-up matters more than the original answer. The claim about Washout upthread is stronger than its source supports. I have read…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #67 · Research Methods › N-of-1 designs · 15 Mar 2026 · 31 likes Picking up post #64: that is the part I would want checked first. Source for the ABAB design figure, since it was asked for. It is in the discussion rather than the…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #69 · Analytics › Mass spectrometry · 14 Mar 2026 · 28 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #13 · Sourcing › Logistics · 8 Mar 2026 · 0 likes Narrowing post #10, because the general version has more than one answer. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 7 Mar 2026 · 26 likes Post #47 describes the usual case. This is about the unusual one. On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #9 · Sourcing › Vendor reports · 4 Mar 2026 · 0 likes Post #6 is right about the mechanism and I think understates the practical bit. The cost of a submission is worth stating. It is the main reason people do not do this…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #35 · Analytics › Impurities & related substances · 24 Feb 2026 · 9 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #57 · Practice › Dosing & titration · 18 Feb 2026 · 0 likes Post #54 answers the question as asked. The question underneath it is different. Half steps are arithmetically simple and pharmacologically unstudied. They are not…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #15 · Outcomes › Body composition · 11 Feb 2026 · 9 likes Post #13 describes the usual case. This is about the unusual one. Adding the boring version of Ultrasound and skinfolds, because the interesting version keeps getting…
Coverage in the US: a map of the usual obstacles Replied, post #42 · Regional › North America · 27 Jan 2026 · 13 likes Taking post #40 at face value and following it one step further. The arithmetic on coverage is the easy part and it is where the errors are, which is an uncomfortable…
Request: export my own posts Replied, post #3 · Meta › Feature requests · 26 Jan 2026 · 0 likes The opening post is the version of this I will quote in future. One addition. Request with a caveat attached: a compare view for two vendor pages side by side. The…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #64 · Pharmacology › Pharmacokinetics · 20 Jan 2026 · 0 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
Second pass at: What to keep a record of at the point of payment Replied, post #2 · Sourcing › Payments · 11 Jan 2026 · 23 likes An invoice that names the lot is unusual and useful, because it ties the commercial record to the material record.
A partial dose because the pen emptied mid-injection Replied, post #73 · Practice › Administration · 9 Jan 2026 · 9 likes Seconded. It reads as careful rather than confident, which is the right register.
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #22 · Documentation › Wiki requests · 3 Jan 2026 · 22 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important.
Follow-up: The decimal-point error, and the habit that catches it Replied, post #124 · Practice › Reconstitution · 21 Dec 2025 · 22 likes Post #121 is the version of this I will quote in future. One addition. Decimal-point error is one of those subjects where the general answer and the answer for a…
The anatomy of a question that gets answered within an hour — the long version Replied, post #121 · Start Here › How to Ask · 20 Nov 2025 · 18 likes Narrowing post #118, because the general version has more than one answer. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
Prescription requirements and telehealth models Replied, post #21 · Sourcing › Regulatory · 19 Nov 2025 · 1 like Reframing prescription requirements and telehealth models slightly, because I think the disagreement is about the question rather than the answer. If the question is…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #4 · Research Methods › N-of-1 designs · 19 Nov 2025 · 0 likes Regression to the mean explains a great many personal experiments. People start when things are at their worst, and things at their worst tend to improve. Someone will…
EMA product information as a primary source Replied, post #69 · Regional › European Union · 15 Nov 2025 · 3 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
Batch date after test date, and other internal inconsistencies Replied, post #17 · Analytics › COA interpretation · 14 Nov 2025 · 7 likes I have been on both sides of the batch date argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #5 · Compounds › Tirzepatide · 5 Nov 2025 · 0 likes Worth separating two things that the opening post runs together. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical…
Sleep quality changes during weight loss — what changed since Replied, post #52 · Wellbeing › Sleep · 5 Nov 2025 · 8 likes Where somebody uses positive airway pressure, changes in weight can change the pressure requirement, and that is a review question rather than a self-adjustment.
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #71 · Compounds › Semaglutide · 7 Oct 2025 · 1 like Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Reading SURMOUNT-1 without the press release Replied, post #25 · Compounds › Tirzepatide · 5 Oct 2025 · 5 likes Reading SURMOUNT-1 without the press was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
The nausea timeline across the first four weeks, with a tabulated log Replied, post #79 · Practice › Side effects · 20 Sep 2025 · 18 likes I would be cautious about generalising from the nausea timeline example above. It is a good example. It is one example.
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #39 · Evidence › Preprints · 23 Aug 2025 · 3 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #4 · Analytics › Method validation · 25 Jul 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Where a pharmacopoeial monograph exists, a method that follows it inherits…
Sodium, potassium and magnesium when intake drops Replied, post #55 · Nutrition & Training › Hydration & electrolytes · 12 Jul 2025 · 0 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #64 · Clinical › Comorbidities · 3 Jul 2025 · 7 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist. Happy to expand any of…
Preparing for an appointment: one page, three questions Replied, post #25 · Clinical › Prescriber conversations · 30 Jun 2025 · 8 likes Take the actual numbers and the actual dates. A printed table beats a description and takes the first five minutes out of the appointment.
Counter-ion content and its effect on measured mass Replied, post #64 · Analytics › Mass spectrometry · 14 Jun 2025 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
[2026 update] An appeal that failed, and what I would do differently Replied, post #32 · Access › Insurance & coverage · 8 Jun 2025 · 7 likes Picking up post #31: that is the part I would want checked first. Appeal is well covered in the tag pages, and the older discussions are better than the recent ones…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #99 · Devices › Cold chain · 8 May 2025 · 2 likes This is the sort of exchange that makes the archive worth searching.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #12 · Evidence › Trials · 16 Apr 2025 · 1 like Post #10 and I disagree about the size of the effect, not about the direction. Nothing in a trial report is medical advice about an individual, and the gap between a…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #73 · Sourcing › Vendor reports · 17 Mar 2025 · 22 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Validating a method you did not develop — does this still hold? Replied, post #117 · Analytics › Method validation · 15 Mar 2025 · 28 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
Scheduled maintenance and what will be unavailable Replied, post #54 · Meta › Announcements · 25 Feb 2025 · 11 likes Where I would push back on the scheduled maintenance consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #123 · Evidence › Journal club · 11 Feb 2025 · 4 likes Post #121 is right about the mechanism and I think understates the practical bit. A definition problem is doing most of the work in this SURPASS-2 discussion. Once the…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #35 · Access › International · 9 Feb 2025 · 0 likes Post #31 put the caveat in the right place and I want to underline it. Where I have landed on Cross-border purchase within, having got it wrong once in public: the…
Prior authorisation: what the criteria usually require Replied, post #4 · Access › Insurance & coverage · 7 Feb 2025 · 0 likes Formulary changes happen on a published schedule, so a denial now may be answering criteria that change shortly. I would rather be precise about what I do not know than…
Distinguishing a deletion sequence by mass alone Replied, post #39 · Analytics › Mass spectrometry · 1 Feb 2025 · 17 likes Confirming post #36 from a second method, which matters more than confirming it from a second person. An acylated peptide has a mass that reflects the modification, so…
Body image changing more slowly than the body Replied, post #82 · Wellbeing › Mental health · 20 Dec 2024 · 22 likes Relationship with food changing is one of the most commonly described experiences here and is discussed far less than the physical effects.
[2026 update] New subcategory: rationale and scope Replied, post #41 · Meta › Announcements · 4 Dec 2024 · 21 likes Since New subcategory keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
When to suspect the method rather than the sample Replied, post #38 · Analytics › Method validation · 17 Nov 2024 · 3 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #24 · Access › Insurance & coverage · 12 Nov 2024 · 10 likes Reframing Step therapy requirements slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes.…
What a seizure notice actually says Replied, post #5 · Sourcing › Logistics · 29 Oct 2024 · 2 likes The bit of seizure notice that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
Tracking a preprint to publication: a worked example — the long version Replied, post #46 · Evidence › Preprints · 7 Oct 2024 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. None of the above is…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #69 · Clinical › Prescriber conversations · 2 Oct 2024 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I would hold that lightly until someone with a larger…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #47 · Sourcing › Independent verification · 9 Sep 2024 · 4 likes This follows post #44 rather than contradicting it. How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity,…
High-resolution MS on aggregates and what it can see — one year on Replied, post #10 · Analytics › Mass spectrometry · 11 Aug 2024 · 0 likes Small methodological point on High-resolution: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Where the four-week escalation interval comes from, and what it is not Replied, post #32 · Practice › Dosing & titration · 27 Jun 2024 · 9 likes Post #29 is the version of this I will quote in future. One addition. Having read the whole four-week escalation interval thread before replying: the question in the…